Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FZ596
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,239
Award facts
- Contract value 100% obligated
- $30,239.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $30,239.14 delivery order to Amerisourcebergen Drug Corp on June 3, 2026, for RINVOQ ER 15 MG tablets (30-count units). Ultimate completion date is June 4, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier to federal healthcare systems, competing on a full-and-open basis across DLA Troop Support Medical procurement vehicles.
Quick answers
Who was awarded contract SPE2DR26FZ596?
SPE2DR26FZ596 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2026.
How much is contract SPE2DR26FZ596 worth?
The government has obligated $30,239 on SPE2DR26FZ596.
Is contract SPE2DR26FZ596 an order under another contract?
Yes. SPE2DR26FZ596 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FZ596 competed?
The extent of competition for SPE2DR26FZ596 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award